The percentage of adults 18 years of age and older who self-report receiving an influenza vaccine within the measurement period. This measure is collected via the CAHPS 5.0H adults survey for Medicare, Medicaid, and commercial populations. It is reported as two separate rates stratified by age: 18-64 and 65 years of age and older.
The percentage of discharges for patients 18 years of age and older who had a visit to the emergency department with a primary diagnosis of mental health or alcohol or other drug dependence during the measurement year AND who had a follow-up visit with any provider with a corresponding primary diagnosis of mental health or alcohol or other drug dependence within 7- and 30-days of discharge.
Four rates are reported:
- The percentage of emergency department visits for mental health for which the patient received follow-up within 7 days of discharge.
The percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and who had a follow-up visit with a mental health provider. Two rates are reported:
1. The percentage of discharges for which the member received follow-up within 30 days after discharge.
2. The percentage of discharges for which the member received follow-up within 7 days after discharge.
Percentage of new antipsychotic prescriptions for Medicaid beneficiaries age 18 years and older who have completed a follow-up visit with a provider with prescribing authority within four weeks (28 days) of prescription of an antipsychotic medication.
The percentage of Medicaid deliveries that had the following number of expected prenatal visits:
• less than 21 percent of expected visits.
• 21 percent–40 percent of expected visits.
• 41 percent–60 percent of expected visits.
• 61 percent–80 percent of expected visits.
• greater than or equal to 81 percent of expected visits.
The percentage of patients with COPD who are found to increase their functional capacity by at least 25 meters (82 feet), as measured by a standardized 6 minute walk test (6MWT) after par-ticipating in pulmonary rehabilitation (PR).
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients with memory deficits.
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients who exhibit deficits in speech-production.
This measure describes the change in functional communication status subsequent to speech-language pathology treatment related to spoken language comprehension.
This measure describes the change in functional communication status subsequent to speech-language pathology treatment related to spoken language expression.